Pharmaceutical, biological, and microbial preparations used in the treatment of women's genitourinary tract infections and conditions; preparations and substances for medical, therapeutic, or prophylactic use for the treatment and prevention of women's genitourinary tract infections and conditions; intravaginal suppositories being pharmaceutical preparations for improving the vaginal microbiome, the pH of the vaginal region, and preventing and treating women's genitourinary tract infections and conditions; probiotic formulations, namely, suppositories for medical purposes, in particular, for modifying or stabilizing the microbiota of the genitourinary tract, producing beneficial metabolites; probiotic formulations, namely, capsules and suppositories for prophylactic and therapeutic management of female genitourinary infections and recurrent conditions; pharmaceutical preparations for genitourinary microbiome dysbiosis resulting from the use of antibiotic medications for the stabilization of a perturbed vaginal microbiota
Pharmaceuticals